High Tide Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $424M+20.7% YoYTTM through 31 Oct 2025
Net Income -$36.2MTTM through 31 Oct 2025
Free Cash Flow $9.9MTTM through 31 Oct 2025
Margins
| Current | |
|---|---|
| Gross Margin | 27.0% |
| EBITDA Margin | 1.7% |
| Operating Margin | -2.4% |
| Net Margin | -8.5% |
Returns
-44.9%ROE
5.1%ROA
Balance Sheet Health
Debt / Equity0.89x
Current Ratio1.46x
Net Debt$27.1M
Cash & Equivalents$47.9M
Quality Metrics
Piotroski F-Score2 / 9
FCF Margin2.3%
Rule of 4025.7
Earnings-Beat Rate75.0%
Dividend
No dividend
Capital Allocation
Capex Intensity2.4%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical Cannabis Distribution | $31.6M | View detailsGermany remains a key growth market and a platform for broader European expansion, supported by combining Remexian's German distribution platform with High Tide's Canadian procurement scale. | |
| Bricks-and-mortar Retail | $147.7M | +7.2% | View detailsThe company continues to expand its Canna Cabana network, aiming to exceed 350 locations across Canada in the long term. |
Financials converted at 1.3981 from CAD.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.